PharmEasy
Edit

PharmEasy

https://www.pharmeasy.in/
Last activity: 23.06.2025
Active
Categories: DiagnosticsDrugHealthTechInformationITLocalMedTechOnlineProductService
PharmEasy is one of India’s leading healthcare aggregators and most trusted medicine delivery app - Android /iOS. We help patients connect with local pharmacy stores and diagnostic centers in order to fulfill their extensive medical needs. Our aim is to revolutionize and improve the entire supply chain in the pharma sector by completely digitizing the process.

How do we do that?

- Make the industry data driven by providing doctors and patients the most accurate information to make informed decisions
- Make healthcare a universal right by making it quantum's cheaper and accessible
- Construct a feedback loop for pharma companies enabling them to make better medicines to combat diseases like never before
- Eradicate fake medicines which contribute to 30% of drug volume in
India

We’ve tied up with hundreds of offline retailers and authorized phlebotomist to make all genuine medicines available to you, as well as quality diagnostics services.

What makes us stand out from our competitors is we offer FLAT 20% OFF on every medicine order and UP TO 75% discounts on diagnostics tests.

Our persistent efforts have helped us to competently serve over 2 lakh families across India. We’ve touched more than 5 lakh lives and helped them save over INR 20 crores on medical expenses.

Currently, we serve customers in Mumbai, Thane, Navi Mumbai, Pune, Ahmedabad, Jaipur, Delhi, Noida, Gurugram, Kolkata and Bengaluru.

Going further, we aim to expand our geographical presence and penetrate further into existing markets to strengthen our category-leadership position.

For the latest updates, follow us on LinkedIn, Twitter and Instagram.
Likes
111.41K
Followers
152.04K
Website visits
17.4M /mo.
Mentions
139
Location: India, Maharashtra, Mumbai
Employees: 1001-5000
Total raised: $2.24B
Valuation: $5B
Founded date: 2015

Investors 11

Show more

Funding Rounds 10

DateSeriesAmountInvestors
04.05.2024-$316M-
23.08.2023-$423.05K-
10.11.2021IPO$842M-
20.10.2021Pre-IPO$350M-
25.06.2021Series C$200MBessemer V...
15.04.2021Series E$350MProsus
29.09.2018Series C$50MEight Road...
26.04.2017Series B$18MBessemer V...
03.04.2017Series B$17M-
-Series D$100M-

Mentions in press and media 139

DateTitleDescription
24.06.2025The Rise of New Ventures: Transforming India’s Home and Investment LandscapesIn the bustling marketplace of India, two new ventures are emerging, poised to reshape their respective industries. All Home, a brainchild of the founders of PharmEasy, is stepping into the home improvement arena. Meanwhile, LaunchBay Capit...
23.06.2025PharmEasy Founders Enter $120M Interior Design Venture Operating quietly in stealth mode over the last six months, All Home claims to have reached operational profitability and scale with brands like ...In a notable pivot from healthcare to home improvement, PharmEasy co-founders Dharmil Sheth, Dhaval Shah, and Hardik Dedhia have launched All Home, a new venture aimed at organizing India's fragmented architectural and interior design marke...
23.06.2025PharmEasy Cofounders Enter Architectural & Interior Design Space With New StartupSUMMARY All Home has raised an undisclosed capital from Bessemer Venture Partners at a valuation of $120 Mn All Home will partner with brands by backing and offering them technology support, internet-led manufacturing and distribution and m...
23.06.2025PharmEasy founders raise capital for new interior design startup All HomeCredit: Pixabay PharmEasy founders Dharmil Sheth, Dhaval Shah, and Hardik Dedhia have raised an undisclosed amount of funding for their new venture, All Home, an interior design and home improvement platform. The funding round was led by Be...
23.06.2025PharmEasy founders launch home improvement venture All Home, raise seed round at $120M valuationDharmil Sheth, Dhaval Shah, and Hardik Dedhia, the founders of online pharmacy startup PharmEasy, have launched All Home, an interior design and home improvement venture. The platform aims to be a one-stop shop for all interior needs by par...
13.06.2025ArisInfra Files RHP to Raise INR 500 Crore via IPO, Eyes Debt Repayment and Expansion The company plans to allocate INR 204.6 crore towards debt repayment. According to the RHP, ArisInfra's total debt...ArisInfra, a B2B ecommerce firm operating in the infrastructure supply chain sector, has filed its red herring prospectus (RHP) to raise INR 499.6 crore through an initial public offering, nearly seven months after receiving regulatory appr...
12.06.2025ArisInfra Files Papers for INR 500 Cr IPO; Issue To Open On June 18SUMMARY The B2B ecommerce company's IPO will consist solely of a fresh issue component via which it will be raising INR 499.6 Cr The PharmEasy-backed company filed its DRHP in August for an INR 600 Cr IPO In January, ArisInfra raised INR 80...
04.06.2025Bessemer Venture Partners appoints former Cisco Investment exec as partnerPankaj Mitra, partner, Bessemer Venture Silicon Valley-based venture capital firm Bessemer Venture Partners, which closed its second India-focused fund in March, said on Wednesday that it has named a former executive at Cisco’s venture capi...
28.05.2025Quadria Capital's Bold Bet on Asian Healthcare: A $1 Billion Investment SurgeIn a world where healthcare is a lifeline, Quadria Capital has thrown down the gauntlet. The New Delhi-based private equity firm recently announced the final close of its third healthcare-focused fund, amassing a staggering $1.07 billion. T...
27.05.2025Quadria Capital closes over a $1B fundQuadria Capital on Tuesday announced the final close of its third healthcare-focused fund at $1.07 billion, exceeding its original target of $800 million. The oversubscribed fund includes $954 million in primary capital and $114 million in ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In